Learn About Rotor Syndrome

What is the definition of Rotor Syndrome?

Rotor syndrome is a relatively mild condition characterized by elevated levels of a substance called bilirubin in the blood (hyperbilirubinemia). Bilirubin is produced when red blood cells are broken down. It has an orange-yellow tint, and buildup of this substance can cause yellowing of the skin or whites of the eyes (jaundice). In people with Rotor syndrome, jaundice is usually evident shortly after birth or in childhood and may come and go; yellowing of the whites of the eyes (also called conjunctival icterus) is often the only symptom.

What are the causes of Rotor Syndrome?

The SLCO1B1 and SLCO1B3 genes are involved in Rotor syndrome. Mutations in both genes are required for the condition to occur. The SLCO1B1 and SLCO1B3 genes provide instructions for making similar proteins, called organic anion transporting polypeptide 1B1 (OATP1B1) and organic anion transporting polypeptide 1B3 (OATP1B3), respectively. Both proteins are found in liver cells; they transport bilirubin and other compounds from the blood into the liver so that they can be cleared from the body. In the liver, bilirubin is dissolved in a digestive fluid called bile and then excreted from the body.

How prevalent is Rotor Syndrome?

Rotor syndrome is a rare condition, although its prevalence is unknown.

Is Rotor Syndrome an inherited disorder?

This condition is inherited in an autosomal recessive pattern. In autosomal recessive inheritance, both copies of a gene in each cell have mutations. In Rotor syndrome, an affected individual must have mutations in both the SLCO1B1 and the SLCO1B3 gene, so both copies of the two genes are altered. The parents of an individual with this condition each carry one altered copy of both genes, but they do not show signs and symptoms of the condition.

Who are the top Rotor Syndrome Local Doctors?
Internal Medicine
Internal Medicine

Holland Community Hospital

3235 N Wellness Dr, 120b Internal Medicine North, 
Holland, MI 
 (12.0 mi)
Experience:
21+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Tyler Murphy is an Internal Medicine provider in Holland, Michigan. Dr. Murphy has been practicing medicine for over 21 years and is rated as an Experienced provider by MediFind in the treatment of Rotor Syndrome. His top areas of expertise are Seasonal Affective Disorder (SAD), Ascites, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Murphy is currently accepting new patients.

Family Medicine
Family Medicine

Grand Valley Medical Specialists Plc

2093 Health Dr Sw, Suite 200, 
Wyoming, MI 
 (14.3 mi)
Languages Spoken:
English
Accepting New Patients

Elizabeth Brouwer is a Family Medicine provider in Wyoming, Michigan. Dr. Brouwer and is rated as an Experienced provider by MediFind in the treatment of Rotor Syndrome. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Macroamylasemia, and Hypertension. Dr. Brouwer is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Family Medicine
Family Medicine

Grand Valley Medical Specialists Plc

2093 Health Dr Sw, Suite 200, 
Wyoming, MI 
 (14.3 mi)
Languages Spoken:
English
Accepting New Patients

John Hamersma is a Family Medicine provider in Wyoming, Michigan. Dr. Hamersma and is rated as an Experienced provider by MediFind in the treatment of Rotor Syndrome. His top areas of expertise are Vitamin D Deficiency, Macroamylasemia, Melorheostosis with Osteopoikilosis, and Osteopenia. Dr. Hamersma is currently accepting new patients.

What are the latest Rotor Syndrome Clinical Trials?
Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect

Summary: Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life. Baby Detect Project is an innovative NBS program using a pane...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I/II, Open Label, Study to Evaluate Safety and Efficacy of an Intravenous Injection of GT-UGT1A1-AAV8-02 (AAV Vector Expressing the UGT1A1 Transgene) in Patients with Crigler-Najjar Syndrome Type I Requiring Phototherapy

Summary: This is a Phase 1/2, multinational, open-label, study to evaluate the safety and efficacy of an intravenous infusion of GT-UGT1A1-AAV8-02 in patients with Crigler-Najjar type 1 aged ≤10 years and requiring phototherapy. Patients will received a single administration of GT-UGT1A1-AAV8-02 and will be followed for safety and efficacy of approximately 60 months (5 years): * a follow-up of approximatel...

Who are the sources who wrote this article ?

Published Date: March 01, 2013
Published By: National Institutes of Health